Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Precigenetics

Tracked across 2 events · 14 articles · First seen Aug 08, 2026 · Last active Sep 15, 2026

Sentiment
35
Attention
2
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 70
Tech
Impact: Precigenetics is the central innovator, developing the live-cell observation platform and related technologies, positioning it for growth in the biotech market.
Aug 08, 2026 · 6 articles
2 0
Business
GSK plc announced on September 15, 2026 that it has entered an agreement to acquire a potential best-in-class trispecific T cell-engager (TCE) for multiple myeloma from privately held clinical-stage biotechnology firm Chimagen Biosciences. The agreement…
Impact: Precigenetics is mentioned only as a better-ranked biotech stock in the sector comparison, with no direct role in the GSK-Chimagen transaction.
Sep 15, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Precigenetics live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.